Furthermore, the Aβ plaques found in AD patients activate the nuclear factor kappa-light-chain-enhancer (NF-κB), upregulating the transcription of cytokines and chemokines involved in inflammation [47]. The gene discussed is NFKB1; the disease is Alzheimer disease.